{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:57:35Z","timestamp":1761487055470},"reference-count":34,"publisher":"Elsevier BV","issue":"9-10","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.vaccine.2003.09.022","type":"journal-article","created":{"date-parts":[[2003,10,25]],"date-time":"2003-10-25T20:00:13Z","timestamp":1067112013000},"page":"1233-1240","source":"Crossref","is-referenced-by-count":33,"title":["Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Philippe","family":"De Wals","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van Hung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lonny J.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryse","family":"Guay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Drapeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"St-Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.09.022_BIB1","first-page":"125","article-title":"Meningococcal disease and public health: welcome to the \u201990s","volume":"83","author":"Corber","year":"1992","journal-title":"Can. J. Public Health"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB2","first-page":"407","article-title":"Impact of mass immunization campaign against serogroup C meningococcus in the province of Quebec","volume":"74","author":"De Wals","year":"1996","journal-title":"Canada. Bull WHO"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.273.5.383","article-title":"Serogroup C meningococcal outbreaks in the United States. An emerging threat","volume":"273","author":"Jackson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB4","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1016\/S0264-410X(01)00205-5","article-title":"and the Meningococcal Disease Advisory Board. Conference report. European Advisory Board meeting Vienna, Austria, 6\u20138 October, 2000","volume":"19","author":"Cartwright","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.285.2.177","article-title":"Five-year study of the effectiveness of polysaccharide vaccine against serogroup C meningococcal disease","volume":"285","author":"De Wals","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB6","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"J\u00f3dar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB7","unstructured":"Bureau de surveillance \u00e9pid\u00e9miologique, Direction de la protection de la sant\u00e9 publique. Flash meningo, volume 1, num\u00e9ro 11. Qu\u00e9bec: Minist\u00e8re de la Sant\u00e9 et des Services sociaux; 2002."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB8","unstructured":"Excel 2000. Microsoft Corporation, Mountain View (California); 2000."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB9","unstructured":"Statistics Canada. Life tables, Canada and Provinces 1990\u20131992. Catalogue 84-537 Occasional. Ottawa; 1996."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB10","doi-asserted-by":"crossref","unstructured":"Erickson P, Wilson RW, Shannon I, Years of healthy life. Statistical note number 7. Hyattsville, MD, USA. National Centre for Health Statistics; 1995.","DOI":"10.1037\/e583992012-001"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB11","unstructured":"Statistics Canada. Gains moyens selon le sexe et le regime de travail; 2000 (at http:\/\/www.statscan.ca)."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB12","unstructured":"Statistics Canada. Population active et taux d\u2019activit\u00e9 selon le sexe et l\u2019\u00e2ge; 2000 (at http:\/\/www.statscan.ca)."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB13","unstructured":"Delbecq AL, Van de Ven AH, Gustafson DH, Group techniques for program planning: a guide to nominal group and Delphi processes. Glenview, IL: Scott, Foresman and Company; 1975."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB14","unstructured":"Direction g\u00e9n\u00e9rale de la sant\u00e9 publique. Protocole d\u2019intervention. Infections m\u00e9ningococciques. Mise \u00e0 jour 1999. Qu\u00e9bec: Minist\u00e8re de la Sant\u00e9 et des Services sociaux; 1999."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB15","unstructured":"National Advisory Committee on Immunization (NACI). Statement on recommended use of meningococcal vaccines. CCDR 2001 27: ACS-6."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB16","unstructured":"Beutels P., Economic evaluation of vaccination programmes in humans. Universiteit Antwerpen, Faculteit Geneeskunde, Vakgroep Epidemiologie en sociale Geneeskunde, Antwerpen, Belgium; 2002."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB17","unstructured":"Statistics Canada. Consumer price index, 1996 classification, annual average indexes, Canada and provinces; 2001 (at http:\/\/www.statscan.ca)."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB18","doi-asserted-by":"crossref","unstructured":"Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.","DOI":"10.1093\/oso\/9780195108248.001.0001"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB19","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/S0264-410X(02)00161-5","article-title":"Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec","volume":"20","author":"De Wals","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB20","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunization campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/520303","article-title":"Complications and sequelae of meningococcal disease in Quebec, Canada, 1990\u20131994","volume":"26","author":"Erickson","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB22","unstructured":"Direction de la protection de la sant\u00e9 publique, Minist\u00e8re de la sant\u00e9 et des services sociaux du Qu\u00e9bec. \u00c9pid\u00e9miologie des infections invasives \u00e0 m\u00e9ningocoques, ann\u00e9e 2001. Flash M\u00e9ningo 2002;1(11):1\u20134."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(03)12563-9","article-title":"Effectiveness of meningococcal conjugate vaccine in teenagers in England","volume":"361","author":"Bose","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB25","unstructured":"Direction g\u00e9n\u00e9rale de la sant\u00e9 publique. Priorit\u00e9s nationales de sant\u00e9 publique 1997-2001. Vers l\u2019atteinte des r\u00e9sultats attendus: 2e bilan. Qu\u00e9bec: Minist\u00e8re de la Sant\u00e9 et des Services sociaux; 2000."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB26","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1016\/S0264-410X(03)00361-X","article-title":"Benefits and costs of immunization of children with pneumococcal cnjugate vaccine in Canada","volume":"21","author":"De Wals","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0264-410X(01)00437-6","article-title":"The cost-effectiveness of varicella vaccination in Canada","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00006454-200206000-00012","article-title":"Instituting a routine varicella vaccination program in Canada: an economic evaluation","volume":"21","author":"Getsios","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bmj.324.7341.809","article-title":"Modeling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales","volume":"324","author":"Trotter","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2003.09.022_BIB30","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of three different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB32","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/IAI.68.5.2692-2697.2000","article-title":"Mucosal immune responses to meningococcal Group C conjugate and Group A and C polysaccharide vaccines in adolescents","volume":"68","author":"Zhang","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-200203000-00010","article-title":"Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants","volume":"21","author":"Zhang","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.022_BIB34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T23:50:16Z","timestamp":1704930616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03006959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":34,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0264410X03006959"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.09.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}